Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial

Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial. (2022). BMJ, e068407. https://doi.org/10.1136/bmj-2021-068407
Authors:
Behnood Bikdeli
Azita H. Talasaz
Babak Sharif-Kashani
Farid Rashidi
Mohammad Taghi Beigmohammadi
Keivan Gohari Moghadam
Somaye Rezaian
Ali Dabbagh
Seyed Hashem Sezavar
Mohsen Farrokhpour
Hooman Bakhshandeh
Atefeh Abedini
Rasoul Aliannejad
Taghi Riahi
Mahdi Yadollahzadeh
Somayeh Lookzadeh
Parisa Rezaeifar
Samira Matin
Ouria Tahamtan
Keyhan Mohammadi
Elnaz Zoghi
Hamid Rahmani
Seyed Hossein Hosseini
Seyed Masoud Mousavian
Homa Abri
Pardis Sadeghipour
Elahe Baghizadeh
Farnaz Rafiee
Sepehr Jamalkhani
Ahmad Amin
Bahram Mohebbi
Seyed Ehsan Parhizgar
Mahshid Soleimanzadeh
Maryam Aghakouchakzadeh
Vahid Eslami
Pooya Payandemehr
Hossein Khalili
Hamed Talakoob
Taranom Tojari
Shadi Shafaghi
Samrand Fattah Ghazi
Sanaz Tabrizi
Hessam Kakavand
Alireza Kashefizadeh
Shaghayegh Shahmirzaei
Atabak Najafi
Mohammad Fathi
David Jimenez
Aakriti Gupta
Mahesh V. Madhavan
Sanjum S. Sethi
Sahil A. Parikh
Manuel Monreal
Naser Hadavand
Alireza Hajighasemi
Khalil Ansarin
Majid Maleki
Saeed Sadeghian
Gregory Piazza
Ajay J. Kirtane
Benjamin W. Van Tassell
Gregg W. Stone
Gregory Y.H. Lip
Harlan M. Krumholz
Samuel Z. Goldhaber
Parham Sadeghipour
Affiliated Authors:
Mahesh V. Madhavan
Sanjum S. Sethi
Sahil A. Parikh
Ajay J. Kirtane
Publication Type:
Article
Unique ID:
10.1136/bmj-2021-068407
PMID:
Journal:
Publication Date:
Data Source:
Scopus

Record Created: